拱东医疗(605369) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 reached ¥282,308,334.04, an increase of 10.94% compared to the same period last year[6] - Net profit attributable to shareholders for Q3 2024 was ¥46,103,046.33, representing a significant increase of 68.91% year-over-year[6] - Net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was ¥45,586,650.97, up 63.29% from the previous year[6] - Basic earnings per share for Q3 2024 were ¥0.29, reflecting a growth of 61.11% compared to the same quarter last year[6] - Total operating revenue for the first three quarters of 2024 reached CNY 836,032,757.64, an increase from CNY 712,681,564.18 in the same period of 2023, representing a growth of approximately 17.4%[17] - Net profit for the third quarter of 2024 was CNY 141,382,840.75, compared to CNY 88,249,716.27 in the third quarter of 2023, reflecting a year-over-year increase of about 60.1%[18] - Basic and diluted earnings per share for the third quarter of 2024 were both CNY 0.90, up from CNY 0.56 in the same quarter of 2023, indicating a significant improvement in profitability[19] - Operating profit for the first three quarters of 2024 was CNY 158,399,713.23, compared to CNY 98,848,254.53 in the same period of 2023, representing an increase of approximately 60.4%[18] - The total comprehensive income for the third quarter of 2024 was CNY 135,771,968.77, compared to CNY 99,481,772.30 in the same quarter of 2023, reflecting a growth of approximately 36.4%[19] Assets and Liabilities - Total assets as of the end of Q3 2024 amounted to ¥1,987,016,890.94, a 5.82% increase from the end of the previous year[6] - The company's total assets amounted to CNY 1,987,016,890.94 in Q3 2024, an increase from CNY 1,877,685,229.51 in Q3 2023, indicating a growth of about 5.8%[17] - Total liabilities increased to CNY 311,104,615.36 in Q3 2024, compared to CNY 239,146,257.53 in Q3 2023, marking an increase of approximately 30.1%[17] - Non-current assets totaled approximately ¥1.06 billion, up from ¥1.05 billion at the end of 2023, showing a slight increase of about 0.9%[14] - The total assets of the company reached approximately ¥1.99 billion, compared to ¥1.88 billion at the end of 2023, representing an increase of about 5.9%[14] Shareholder Information - Shareholders' equity attributable to the parent company was ¥1,665,426,161.12, showing a 1.64% increase compared to the previous year[6] - The total number of common shareholders at the end of the reporting period is 7,376, with the largest shareholder holding 50.24% of the shares[10] - The number of shares held by the top ten shareholders includes significant stakes from both domestic and foreign individuals, with the largest shareholder holding over 50%[10] - The company has not reported any changes in the financing or margin trading activities of the top ten shareholders[11] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥145,584,021.87, an increase of 27.83% year-over-year[6] - In the first three quarters of 2024, the cash inflow from operating activities reached ¥803,586,701.56, an increase of 12.5% compared to ¥714,247,404.10 in the same period of 2023[20] - The net cash flow from operating activities for the first three quarters of 2024 was ¥145,584,021.87, up 28% from ¥113,892,955.40 in 2023[22] - The total cash outflow from operating activities was ¥658,002,679.69, compared to ¥600,354,448.70 in the previous year, reflecting a 9.6% increase[22] - The ending balance of cash and cash equivalents as of the third quarter of 2024 was ¥502,874,015.62, compared to ¥447,837,688.92 at the end of the same period in 2023[23] - The company experienced a net increase in cash and cash equivalents of ¥105,197,448.44 in the third quarter of 2024, contrasting with a decrease of -¥255,396,308.93 in the same quarter of 2023[22] Investment and Financing Activities - The cash inflow from investment activities was ¥63,226,331.93, significantly higher than ¥11,147,902.99 in the same period last year[22] - The net cash flow from investment activities was -¥30,209,819.55, an improvement from -¥351,158,183.20 in 2023[22] - The cash inflow from financing activities totaled ¥70,500,000.00, while cash outflow was ¥73,856,534.80, resulting in a net cash flow of -¥3,356,534.80[22] - The company received ¥10,500,000.00 from investment absorption in the third quarter of 2024[22] - The company paid ¥34,083,460.17 in dividends and interest during the third quarter of 2024, slightly up from ¥33,788,136.00 in the previous year[22] Operational Performance - The company reported a significant improvement in the operational performance of its U.S. subsidiary, Trademark Plastics Inc.[9] - The company anticipates continued growth in revenue and profitability driven by improved operational efficiencies and market expansion strategies[9] Research and Development - Research and development expenses for the first three quarters of 2024 were CNY 36,769,587.06, slightly higher than CNY 35,469,052.84 in the same period of 2023, indicating continued investment in innovation[17] Goodwill - The company’s goodwill decreased slightly from ¥198.68 million to ¥195.87 million, indicating a reduction of about 1.4%[14]